NCT05468736Phase 2, phase 3Completed

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

Study sponsor: Novavax

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-01-16Actual
Enrollment · participants3600Actual
Source updated2026-05-22Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview